You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2012-09-06 21:02:45 UTC |
---|
Update Date | 2023-02-21 17:18:37 UTC |
---|
HMDB ID | HMDB0028854 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Glycylvaline |
---|
Description | Glycylvaline, also known as GV or gly-L-val, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Glycylvaline has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make glycylvaline a potential biomarker for the consumption of these foods. Glycylvaline is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on Glycylvaline. |
---|
Structure | CC(C)[C@H](NC(=O)CN)C(O)=O InChI=1S/C7H14N2O3/c1-4(2)6(7(11)12)9-5(10)3-8/h4,6H,3,8H2,1-2H3,(H,9,10)(H,11,12)/t6-/m0/s1 |
---|
Synonyms | Value | Source |
---|
Gly-L-val | ChEBI | Glycyl-valine | ChEBI | GV | ChEBI | Glycylvaline, (L)-isomer | HMDB | Glycylvaline, (D)-isomer | HMDB | Gly-val | HMDB | g-V Dipeptide | HMDB | GV Dipeptide | HMDB | Glycine valine dipeptide | HMDB | Glycine-valine dipeptide | HMDB | Glycyl-L-valine | HMDB | N-Glycyl-L-valine | HMDB | N-Glycylvaline | HMDB | Glycylvaline | ChEBI |
|
---|
Chemical Formula | C7H14N2O3 |
---|
Average Molecular Weight | 174.2 |
---|
Monoisotopic Molecular Weight | 174.100442319 |
---|
IUPAC Name | (2S)-2-(2-aminoacetamido)-3-methylbutanoic acid |
---|
Traditional Name | gly-val |
---|
CAS Registry Number | 1963-21-9 |
---|
SMILES | CC(C)[C@H](NC(=O)CN)C(O)=O |
---|
InChI Identifier | InChI=1S/C7H14N2O3/c1-4(2)6(7(11)12)9-5(10)3-8/h4,6H,3,8H2,1-2H3,(H,9,10)(H,11,12)/t6-/m0/s1 |
---|
InChI Key | STKYPAFSDFAEPH-LURJTMIESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Dipeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-dipeptide
- N-acyl-alpha amino acid or derivatives
- N-acyl-alpha-amino acid
- Valine or derivatives
- N-acyl-l-alpha-amino acid
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty acyl
- Fatty acid
- Amino acid or derivatives
- Secondary carboxylic acid amide
- Amino acid
- Carboxamide group
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Primary aliphatic amine
- Primary amine
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | -3.06 | Extrapolated |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 137.394 | 30932474 | DeepCCS | [M-H]- | 134.088 | 30932474 | DeepCCS | [M-2H]- | 171.054 | 30932474 | DeepCCS | [M+Na]+ | 146.592 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Glycylvaline,1TMS,isomer #1 | CC(C)[C@H](NC(=O)CN)C(=O)O[Si](C)(C)C | 1615.3 | Semi standard non polar | 33892256 | Glycylvaline,1TMS,isomer #2 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O | 1659.3 | Semi standard non polar | 33892256 | Glycylvaline,1TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN)[Si](C)(C)C | 1567.5 | Semi standard non polar | 33892256 | Glycylvaline,2TMS,isomer #1 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1705.6 | Semi standard non polar | 33892256 | Glycylvaline,2TMS,isomer #1 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1637.3 | Standard non polar | 33892256 | Glycylvaline,2TMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN)[Si](C)(C)C | 1579.6 | Semi standard non polar | 33892256 | Glycylvaline,2TMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN)[Si](C)(C)C | 1650.8 | Standard non polar | 33892256 | Glycylvaline,2TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1672.3 | Semi standard non polar | 33892256 | Glycylvaline,2TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1665.9 | Standard non polar | 33892256 | Glycylvaline,2TMS,isomer #4 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1851.1 | Semi standard non polar | 33892256 | Glycylvaline,2TMS,isomer #4 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1728.6 | Standard non polar | 33892256 | Glycylvaline,3TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1691.3 | Semi standard non polar | 33892256 | Glycylvaline,3TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1740.9 | Standard non polar | 33892256 | Glycylvaline,3TMS,isomer #2 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1859.6 | Semi standard non polar | 33892256 | Glycylvaline,3TMS,isomer #2 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1792.8 | Standard non polar | 33892256 | Glycylvaline,3TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1817.6 | Semi standard non polar | 33892256 | Glycylvaline,3TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1813.5 | Standard non polar | 33892256 | Glycylvaline,4TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1862.7 | Semi standard non polar | 33892256 | Glycylvaline,4TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1878.3 | Standard non polar | 33892256 | Glycylvaline,1TBDMS,isomer #1 | CC(C)[C@H](NC(=O)CN)C(=O)O[Si](C)(C)C(C)(C)C | 1856.5 | Semi standard non polar | 33892256 | Glycylvaline,1TBDMS,isomer #2 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O | 1898.2 | Semi standard non polar | 33892256 | Glycylvaline,1TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 1819.6 | Semi standard non polar | 33892256 | Glycylvaline,2TBDMS,isomer #1 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2121.7 | Semi standard non polar | 33892256 | Glycylvaline,2TBDMS,isomer #1 | CC(C)[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2046.3 | Standard non polar | 33892256 | Glycylvaline,2TBDMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 2040.2 | Semi standard non polar | 33892256 | Glycylvaline,2TBDMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 2025.3 | Standard non polar | 33892256 | Glycylvaline,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2127.4 | Semi standard non polar | 33892256 | Glycylvaline,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2052.9 | Standard non polar | 33892256 | Glycylvaline,2TBDMS,isomer #4 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2263.0 | Semi standard non polar | 33892256 | Glycylvaline,2TBDMS,isomer #4 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2087.3 | Standard non polar | 33892256 | Glycylvaline,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2359.6 | Semi standard non polar | 33892256 | Glycylvaline,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2311.2 | Standard non polar | 33892256 | Glycylvaline,3TBDMS,isomer #2 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2485.0 | Semi standard non polar | 33892256 | Glycylvaline,3TBDMS,isomer #2 | CC(C)[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2348.6 | Standard non polar | 33892256 | Glycylvaline,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2481.0 | Semi standard non polar | 33892256 | Glycylvaline,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2371.5 | Standard non polar | 33892256 | Glycylvaline,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2712.7 | Semi standard non polar | 33892256 | Glycylvaline,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2595.3 | Standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Glycylvaline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 40V, Positive-QTOF | splash10-0ab9-9000000000-22aab51edd782feb3b80 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 30V, Positive-QTOF | splash10-00di-9000000000-9d3bc041813a172a126c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 30V, Positive-QTOF | splash10-00di-9000000000-b8ca877ca975c7d18478 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 10V, Positive-QTOF | splash10-0100-6900000000-04daf0e06504ac6056aa | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 10V, Positive-QTOF | splash10-0100-5900000000-80aa0418207f00d55130 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 20V, Positive-QTOF | splash10-00di-9000000000-a33d201b189787c83ea7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 0V, Positive-QTOF | splash10-004i-0900000000-adb8ea2796cdb2e0adb5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 30V, Positive-QTOF | splash10-0ab9-9000000000-7079c0a3dd91959e413e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 0V, Positive-QTOF | splash10-016r-0900000000-e28cbd287a513576fcc0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylvaline 10V, Positive-QTOF | splash10-014i-5900000000-783be20fde47c765f0d8 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylvaline 10V, Negative-QTOF | splash10-014i-0900000000-60097e54fbfdc1ecad0e | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylvaline 20V, Negative-QTOF | splash10-014i-4900000000-85f19cdd121d294d41a0 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylvaline 40V, Negative-QTOF | splash10-0006-9000000000-50e48ea605aef64385e3 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylvaline 10V, Positive-QTOF | splash10-004i-1900000000-2c6b23894c901c1ddef1 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylvaline 20V, Positive-QTOF | splash10-00di-9200000000-b4828c40b3415069f101 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylvaline 40V, Positive-QTOF | splash10-0a4i-9000000000-61dea7058a50b0bcf64c | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Asthma | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Asthma | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB111886 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 2006926 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 2724807 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 73922 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Steininger R, Karner J, Roth E, Langer K: Infusion of dipeptides as nutritional substrates for glutamine, tyrosine, and branched-chain amino acids in patients with acute pancreatitis. Metabolism. 1989 Aug;38(8 Suppl 1):78-81. [PubMed:2503685 ]
- Guardiola J, De Felice M, Klopotowski T, Iaccarino M: Mutations affecting the different transport systems for isoleucine, leucine, and valine in Escherichia coli K-12. J Bacteriol. 1974 Feb;117(2):393-405. [PubMed:4590465 ]
- De Felice M, Guardiola J, Lamberti A, Iaccarino M: Escherichia coli K-12 mutants altered in the transport systems for oligo- and dipeptides. J Bacteriol. 1973 Nov;116(2):751-6. [PubMed:4126826 ]
- Zhang CX, Tong HB, Yan CG: First soluble multipolymer MPEG-supported liquid-phase convergent synthesis of tripeptide Fmoc-GlyVal-GlyOH. J Comb Chem. 2007 Nov-Dec;9(6):924-5. Epub 2007 Oct 31. [PubMed:17970597 ]
- SHELTON DC, NUTTER WE: UPTAKE OF VALINE AND GLYCYLVALINE BY LEUCONOSTOC MESENTEROIDES. J Bacteriol. 1964 Oct;88:1175-84. [PubMed:14219035 ]
- Huckle KR, Hutson DH, Millburn P: Species differences in the metabolism of 3-phenoxybenzoic acid. Drug Metab Dispos. 1981 Jul-Aug;9(4):352-9. [PubMed:6114835 ]
- Valenkevich LN: [Clinical importance of the determination of intestinal dipeptidase and enterokinase activity in patients with chronic enteritis]. Ter Arkh. 1987;59(11):88-90. [PubMed:3481658 ]
- Kline EL, Brown CS, Umbarger HE: Effect of a leu-linked mutation on the valine sensitivity of acetohydroxy acid synthase activity in Escherichia coli. J Bacteriol. 1975 Feb;121(2):491-6. [PubMed:1089631 ]
- Nath M, Pokharia S, Eng G, Song X, Kumar A: New triorganotin(IV) derivatives of dipeptides as anti-inflammatory-antimicrobial agents. Eur J Med Chem. 2005 Mar;40(3):289-98. Epub 2005 Jan 4. [PubMed:15725498 ]
|
---|